Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 7, No 4 (2011) SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS Abstract  similar documents
E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts
"... Aim. To study the relations of clinical characteristics and individual warfarin dose titration ..."
 
Vol 8, No 2 (2012) QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL Abstract  similar documents
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
"... of the main group (n=79) completed the international clinical trial with warfarin titration to therapeutic ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... на подбор дозы варфарина, являются генетические особенности [30]. Активность препарата частично ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... Aim. To analyze the structure of expenses associated with warfarin dose adjustment ..."
 
Vol 8, No 4 (2012) WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE Abstract  similar documents
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov
"... Analysis of the current literature data on the use of warfarin in patients with cardioembolic ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... The safety of anticoagulant therapy is discussed. Warfarin position in prevention of thrombotic ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... for usage of pharmacogenetics approach for individual choice of indirect anticoagulant dose regime. However ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic acid) and novel oral ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... fibrillation. Factors of warfarin therapy efficacy, as well as the possibility of new antithrombotic drugs ..."
 
Vol 6, No 5 (2010) THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY Abstract  similar documents
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva
"... in the perioperative continuation or termination of warfarin therapy is shown. Potential of the local hemostatic agents ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... and cohort trials). The use of unreasonably low doses of oral anticoagulants in elderly patients is debated ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... are shown. Use of NOAC in reduced doses prescribing according to RCT and RWD are shown. Our own 13-month ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"... " of the OAC is warfarin, which has proved effectiveness in all categories of patients with AF. A whole group ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
"... response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... Aim. To study the effect of rivaroxaban compared with warfarin on the incidence of cardioembolic ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... complications in atrial fibrillation, including those with concomitant renal pathology, was considered warfarin ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non ..."
 
Vol 4, No 4 (2008) COMPARISON OF DIFFERENT STRATEGIES OF ANTIHYPERTENSIVE THERAPY IN OUT-PATIENT CLINIC Abstract  similar documents
O. A. Plejko, A. O. Konradi
"... therapy based on doses titration and addition of the second (third) drug if necessary. Patients of group ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... . Ключевые слова: артериальная гипертензия, фибрилляция предсердий, ацетилсалициловая кислота, варфарин ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings from ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... of the main studies didn't yield or exceeded warfarin concerning balance of efficiency and safety. However ..."
 
Vol 15, No 5 (2019) Clinical Case: Atypical Warfarin-induced Skin Necrosis Abstract  similar documents
T. V. Kondratieva, L. V. Popova, S. S. Karachev, A. S. Lishuta, M. Z. Kanevskaya
"... Warfarin-induced skin necrosis (WISN) is a rare complication of antivitamin K therapy, which occurs ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... compared with patients of warfarin group. Mutations in CYP2C9 gene were detected in 32.9%, VKORC1 – in 68 ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants such as apixaban ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... Appropriate use of warfarin is not in routine clinical practice despite convincing data ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... cardioversion. Vitamin K antagonists (warfarin) more often used to prepare for electrical cardioversion. However ..."
 
Vol 14, No 5 (2018) Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) Abstract  similar documents
G. S. Krasnov, I. V. Kazancev
"... . As a result of analysis, it was  described two  drug  interactions led to minor bleeding: warfarin ..."
 
Vol 3, No 1 (2007) EFFICACY OF DIFFERENT TACTICS FOR INITIAL ANTIHYPERTENSIVE THERAPY Abstract  similar documents
O. A. Pleyko, A. O. Konrady
"... therapy with gradual dose increase and further addition of second (third) drug. Patients in group “C” were ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... тромбоэмболий, варфарин, дабигатран, ривароксабан, апиксабан. Рациональная Фармакотерапия в Кардиологии 2014 ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... of evidence showing their high safety and efficacy, which in some cases exceed those of warfarin, and also ..."
 
Vol 14, No 1 (2018) THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov
"... in patients with atrial fibrillation (AF) receiving anticoagulant therapy with warfarin. Material and methods ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... -salicylic acid, warfarin). Efficacy and safety of rivaroxaban is considered on the basis of the results ..."
 
Vol 7, No 4 (2011) LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE Abstract  similar documents
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov
"... anticoagulant therapy with warfarin and fraxiparine in patient with dilated cardiomyopathy, congestive heart ..."
 
Vol 9, No 5 (2013) PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
"... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... , warfarin, ticlopidine and clopidogrel are discussed. Study data on new antiplatelet drugs are given ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... and safety of apixaban with these of warfarin in patients with atrial fibrillation and a history of ischemic ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... % at the prehospital stage, of which 19.8% of patients took warfarin and 12.2% – direct OAC. The target level ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... of food products that can affect anticoagulant therapy with warfarin does not have special regional ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... % of the patients received appropriate anticoagulant therapy. Warfarin was prescribed in 73% of the cases, of them ..."
 
Vol 15, No 4 (2019) The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients Abstract  similar documents
M. P. Savenkov, S. N. Ivanov, M. P. Mikhaylusova, M. V. Borschevskaya, A. M. Savenkova, N. Y. Kozachenko, E. S. Sherifova
"... Аim. To study the efficacy, tolerability and safety of using a fixed dose combination of an ACE ..."
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... (1335 from 3169 patients; age 69.1±10.4 years, 43% men), including warfarin (817 patients; 26%) and non ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... of dabigatran in various doses are discussed. Besides, a comparison of dabigatran and varfarin therapies ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... refusal were satisfactory with warfarin (32.6%), the high price of these drugs (23.9%), the description ..."
 
Vol 10, No 2 (2014) SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT Abstract  similar documents
E. A. Drozdova
"... assessment of warfarin and dabigatran therapies is given. ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... . Acetylsalicylic acid was prescribed to 0.7% of cases (n=2), warfarin – to 5% (n=12). High risk of thromboembolic ..."
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... (dabigatran), today are increasingly replacing warfarin and other indirect anticoagulants in preventing stroke ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... . Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered ..."
 
Vol 15, No 5 (2019) Rivaroxaban-Associated Hepatotoxicity: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov
"... .g. warfarin), have a predictable manifestation of the anticoagulant effect and the possibility of using ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... anticoagulants. Combined therapy of antiplatelet drugs with warfarin or new oral anticoagulants results ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... therapy (acetylsalicylic acid, clopidogrel, warfarin) was made on the 4th day of disease onset taking ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... long-term anticoagulant therapy with apixaban in a full dose (5 mg b.i.d.), and the patient ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... therapy in high doses is discussed in patients with IHD and dyslipidemia. Atorvastatin in high doses ..."
 
Vol 8, No 6 (2012) HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
S. V. Moiseev
"... clinical trial dabigatran 150 mg b.i.d was more effective than warfarin in prevention of ischemic stroke ..."
 
Vol 13, No 5 (2017) ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT Abstract  similar documents
S. G. Kanorskii
"... of anticoagulant therapy include vitamin K antagonists, such as warfarin, whose  benefits are long established ..."
 
Vol 9, No 2 (2013) ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS Abstract  similar documents
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov
"... .2% (4/18), and antiplatelet drugs 11.1% (2/18). Conclusion. Warfarin was more often cause of ADR during ..."
 
Vol 14, No 4 (2018) Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case Abstract  similar documents
D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina
"... применением антитромботических препаратов. Подбор антитромботической терапии у них проводится на основании ..."
 
Vol 10, No 1 (2014) TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS Abstract  similar documents
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta
"... inhibitor enalapril are presented. Key words: arterial hypertension, combination therapy, fixed-dose drug ..."
 
Vol 1, No 3 (2005) COMPARATIVE STUDY OF COMBINED DRUGS OF ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE: «RENIPRIL HT» AND «CO-RENITEC» IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
S. Y. Martsevich, J. V. Lukina, A. D. Deev, N. S. Oganisyan, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, V. P. Voronina, M. P. Kozireva
"... ,5 mg daily or CR 10/6,25 mg daily. Within next 2 weeks doses of drugs were doubled if target BP level ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... . The efficacy of high-dose simvastatin (40 mg/day) therapy initiated in acute stage of ischemic stroke ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... doses are presented. In these studies high dose atorvastatin therapy was used in patients with acute ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... . BMJ. 1995;310(6983):827-30. 2. Lanas A., Bajador E., Serrano P., et al. Nitrovasodilators, low-dose ..."
 
Vol 14, No 3 (2018) TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk
"... -dose combination with hydrochlorothiazide, including real clinical practice settings. The evidence base ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... (63.8%). No significant differences were found in daily doses of the main prescribed preventive drugs ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..."
 
Vol 10, No 6 (2014) PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, N. V. Furman
"... .12.2011. Results. Acetylsalicylic acid was prescribed to 66.7% of patients, warfarin – 3.9%. At that target level ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... of venous thromboembolism (VTE) compared with low molecular weight heparin (LMWH)/warfarin and other new ..."
 
Vol 3, No 5 (2007) EFFECT OF ANTIHYPERTENSIVE THERAPY BASED ON NEW METHOD OF INDIVIDUAL CHOICE OF DRUGS ON LEFT VENTRICULAR HYPERTROPHY IN ELDERLY PATIENTS Abstract  similar documents
K. I. Pshenichkin
"... были разделены на две группы по 30 человек. Для больных 1-й группы подбор препаратов осуществлялся на ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... помочь как в подборе дозы варфарина, так и в выявлении резистентных или ги- перчувствительных к нему лиц ..."
 
Vol 8, No 5 (2012) RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE Abstract  similar documents
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman
"...   to  CHADS2 and  CHA2DS2–VASc scales, respectively received warfarin in hospital. All patients with permanent ..."
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... , Vasilip dose was increased significantly more often, than Tulip dose. Average Tulip dose after titration ..."
 
Vol 1, No 2 (2005) PHARMACOKINETIC RESEARCHES AND PRACTICAL MEDICINE Abstract  similar documents
V. G. Belolipetskaya, Y. V. Sukhanov
"... значимости данной науки как для создания новых лекарственных форм препаратов, так и для подбора оптимального ..."
 
Vol 14, No 6 (2018) Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva, O. N. Tkacheva
"... with warfarin reduced the risk of stroke/systemic embolism and ischemic stroke alone in fragile elderly patients ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
"... антикоагулянтами остают- ся антагонисты витамина К (АВК). Лидирующая пози- ция среди них принадлежит варфарину ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... and medical tactics in the titration of doses, as well as the achievement of the target level of low-density ..."
 
Vol 9, No 5 (2013) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva
"... Aim. To study the clinical equivalence of the two low-dose combined drugs on the base of generic ..."
 
Vol 6, No 5 (2010) FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. O. Shevchenko, O. P. Shevchenko
"... Peculiarities of the mode of action and clinical use of fixed low-dose combination of lisinopril ..."
 
Vol 5, No 2 (2009) EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. A. Haisheva
"... hypertension (HT), as well as possibility of their correction by lisinopril or by fixed low dose combination ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... of therapy with atorvastatin in different doses in patients with acute ST-segment elevation myocardial ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
"... schemes and the preferred doses of statins and antiplatelet agents depending on the localization ..."
 
Vol 15, No 2 (2019) Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice Abstract  similar documents
E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova
"... dose combinations and their efficacy in hypertensive patients in the real outpatient practice ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... as the antihypertensive and organoprotective effects of fixed-dose combinations of amlodipine/lisinopril and bisoprolol ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... определений МНО при подборе дозы варфарина и контроле терапии), приводит к нерегулярным визи- там ко врачу и ..."
 
Vol 4, No 5 (2008) EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS Abstract  similar documents
S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya
"... therapy or only basic therapy groups. Enalapril dose titration was performed in all patients. Quality ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... and systemic thromboembolic (STE) complications as warfarin, although DOACs were associated with less risk ..."
 
Vol 2, No 1 (2006) THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY Abstract  similar documents
M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov
"... with the further titration of the dose up to 20 mg daily. Patients of the second group took previous ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accompanied by some ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... of three NOAC) in comparison to warfarin reduced the risk of stroke/systemic embolism and ischemic stroke ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... , coronary angiography use, as well as a scarce prescription of warfarin in AF and statins ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... randomized into 2 groups. Group V/A was treated with valsartan and amlodipine in fixed-dose combinations ..."
 
Vol 13, No 6 (2017) ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina
"... Advantages of amlodipine, lisinopril and their fixed-dose combination are presented regarding ..."
 
Vol 11, No 5 (2015) Practical aspects of apixaban use in clinical practice: continuing the theme Abstract  similar documents
S. N. Bel'diev
"... that apixaban dose should be reduced to 2.5 mg twice daily when co-administered with a strong CYP3A4 and P-gp ..."
 
Vol 10, No 6 (2014) PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING Abstract  similar documents
N. V. Shcherbakova, A. I. Ershova, A. A. Suvorova, E. Y. Hlebus, A. N. Meshkov, S. A. Boytsov
"... to exome sequencing of the participant we did not reveal allelic variants that require dose regime ..."
 
Vol 12, No 1 (2016) Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita Abstract  similar documents
S. N. Bel'diev
"... to preliminary calculations, it seems rational to reduce the dose of rivaroxaban when co-administered ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..."
 
1 - 100 of 610 Items 1 2 3 4 5 6 7 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)